Published in JAMA on January 04, 1985
Effect of electronic patient record use on mortality in End Stage Renal Disease, a model chronic disease: retrospective analysis of 9 years of prospectively collected data. BMC Med Inform Decis Mak (2007) 0.92
Continuous quality improvement in daily clinical practice: a proof of concept study. PLoS One (2014) 0.75
Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity? Am J Kidney Dis (1986) 1.65
Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med (1985) 1.47
Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects. Q J Med (1988) 1.44
Bilateral renal vein thrombosis. Clinical and electron microscopic studies of a case with complete recovery after anticoagulant therapy. Ann Intern Med (1966) 1.42
On-line computerized data handling system for treating patients with renal disease. Arch Intern Med (1977) 1.31
QUANTITATIVE HISTOCHEMISTRY OF THE NEPHRON. III. LACTIC DEHYDROGENASE ACTIVITY IN MAN AND OTHER SPECIES. J Clin Invest (1960) 1.21
Use of enzyme-linked antibodies to measure serum anti-DNA antibody in systemic lupus erythematosus. Clin Chem (1974) 1.20
Lymphocytotoxic antibodies in patients with systemic lupus erythematosus. Clin Exp Immunol (1974) 1.19
Serum transferrin levels in chronic renal failure. Nephron (1972) 1.18
Natural history of lipoid nephrosis and of membranous glomerulonephritis. Ann Intern Med (1968) 1.16
Acute interstitial nephritis. A clinical and pathologic study based on renal biopsies. Am J Med (1975) 1.14
Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) (1981) 1.12
The distribution and character of glomerular deposits in systemic lupus erythematosus. Kidney Int (1972) 1.11
Fatal late postpartum intravascular coagulation with acute renal failure. Am J Med Sci (1969) 1.10
Pre-eclampsia with the nephrotic syndrome. Kidney Int (1978) 1.10
Rapidly progressive (nonstreptococcal) glomerulonephritis. Ann Intern Med (1968) 1.10
Binding of protein to polystyrene in solid-phase immunoassays. Biochim Biophys Acta (1977) 1.09
Rapid differentiation of glomerular and tubular proteinuria by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Clin Chim Acta (1972) 1.08
Anthropometric norms for the dialysis population. Am J Kidney Dis (1990) 1.05
Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation. Am J Nephrol (1982) 1.05
Discontinuities (gaps) of the glomerular capillary wall and basement membrane in renal diseases. Lab Invest (1973) 1.02
Renal tubular interactions of proteins. Clin Biochem (1980) 1.02
Quantitative enzyme patterns in the nephron of the healthy human kidney. Nephron (1970) 1.02
Relationship of levels of circulating immune complexes to histologic patterns of nephritis: a comparative study of membranous glomerulonephropathy and diffuse proliferative glomerulonephritis. J Lab Clin Med (1977) 1.01
The distribution of Tamm Horsfall mucoprotein (uromucoid) in the human nephron. Nephron (1969) 0.99
Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod. J Lab Clin Med (1985) 0.98
Auto-immune disease in NZB and NZB-NZW F1 mice. Natural history and pathology. Arch Pathol (1967) 0.97
Isoelectric point of albumin: effect on renal handling of albumin. Kidney Int (1979) 0.97
Results of treatment in patients with end-stage renal disease: a multivariate analysis of risk factors and survival in 341 successive patients. Am J Kidney Dis (1985) 0.97
QUANTITATIVE HISTOCHEMISTRY OF THE NEPHRON. VI. HYDROXYPROLINE IN THE HUMAN GLOMERULUS. J Clin Invest (1961) 0.97
Antibodies to beta 2 microglobulin in the sera of patients with systemic lupus erythematosus. Immunology (1977) 0.97
Kinetics of oral tolerance: study of variables affecting tolerance induced by oral administration of antigen. Int Arch Allergy Appl Immunol (1984) 0.95
Treatment of lupus nephritis. Adv Nephrol Necker Hosp (1976) 0.95
Renal histologic findings in systemic lupus erythematosus. Mayo Clin Proc (1969) 0.95
Antibody enzyme conjugates: the preparation of intermolecular conjugates of horseradish peroxidase and antibody and their use in immunohistology of renal cortex. J Histochem Cytochem (1973) 0.93
Lobular glomerulonephritis and membranoproliferative glomerulonephritis: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) (1971) 0.93
The effect of treatment with prednisone and nitrogen mustard on the renal lesions and life span of patients with lupus glomerulonephritis. Nephron (1973) 0.90
Is there a role for polyunsaturated fatty acids in the prevention of renal disease and renal failure? Nephron (1985) 0.90
Glutaminase activity in the kidney in gout. J Lab Clin Med (1965) 0.90
Serum proteins in urine: an examination of the effects of some methods used to concentrate the urine. J Lab Clin Med (1966) 0.89
Adult Fanconi syndrome, amyloidosis and marked kappa-light chain proteinuria. Nephron (1973) 0.89
Renal vein thrombosis in the adult: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) (1968) 0.89
Selectivity of proteinuria: an evaluation of the immunochemical and gel filtration techniques. J Lab Clin Med (1970) 0.88
Occupational exposure to lead: effects on renal function. Kidney Int (1980) 0.87
Value of the sieving coefficient in the interpretation of renal protein clearances. Nephron (1974) 0.86
Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney. J Clin Invest (1977) 0.85
Glomerular and vascular "insudative" lesions of diabetic nephropathy: electron microscopic observations. Am J Pathol (1970) 0.85
Chronic membranoproliferative glomerulonephritis. A patient with recurrent episodes simulating rheumatic fever and acute nephritis. Am J Med (1975) 0.85
Albumin and -globulin in the nephron of the normal rat and following the injection of aminonucleoside. Nephron (1972) 0.85
Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb Res (1985) 0.84
The clinical course of lupus nephritis: relationship to the renal histologic findings. Perspect Nephrol Hypertens (1973) 0.84
Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations. Thromb Res (1982) 0.84
Lymphocytotoxins in aging. Transplantation (1974) 0.84
Pancreatitis in patients with end-stage renal disease. Medicine (Baltimore) (1994) 0.84
Induction of oral tolerance in mice unresponsive to bacterial lipopolysaccharide. Infect Immun (1983) 0.84
IgE levels in interstitial nephritis. Lancet (1974) 0.83
Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis (1990) 0.82
Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor. Clin Nephrol (1982) 0.82
Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse. Am J Kidney Dis (1989) 0.82
Renal handling and pathophysiology of Bence Jones proteins. Contrib Nephrol (1981) 0.82
The natural history of the renal manifestations of systemic lupus erythematosus. 1964. J Am Soc Nephrol (1997) 0.81
Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes. Medicine (Baltimore) (1973) 0.81
Circadian rhythms of creatinine and electrolyte excretion in healthy pregnant women. Am J Obstet Gynecol (1969) 0.81
Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. J Lab Clin Med (1984) 0.80
Rapidly progressive glomerulonephritis. Med Clin North Am (1971) 0.80
Prolongation of survival of a heart xenograft by defibrination with ancrod. Transplantation (1983) 0.80
Multiple use of dialyzers: safety and efficacy. Kidney Int (1981) 0.79
Renal vein thrombosis. Postgrad Med (1966) 0.79
Nephrotoxicity of low molecular weight serum proteins: physicochemical interactions between myoglobin, hemoglobin, bence-jones proteins and tamm-horsfall mucoprotein. Curr Probl Clin Biochem (1979) 0.79
Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis. J Lab Clin Med (1985) 0.79
Effect of first and subsequent use of hemodialyzers on patient well-being: the rise and fall of a syndrome associated with new dialyzer use. Artif Organs (1987) 0.79
Proteinuria following renal transplantation. Nephron (1977) 0.78
Repeated use of dialyzers is safe: long-term observations on morbidity and mortality in patients with end-stage renal disease. Nephron (1986) 0.78
Beneficial effects of polyunsaturated fatty acids in partially nephrectomized rats. Prostaglandins (1986) 0.78
Proteinuria and renal protein clearances in patients with renal tubular disorders. J Lab Clin Med (1971) 0.78
Serum proteins in NZB/Bl and related strains of mice. Proc Soc Exp Biol Med (1966) 0.78
Dietary fat in experimental nephrotic syndrome: beneficial effects of fish oil on serum lipids and, indirectly, on the kidney. Life Sci (1987) 0.77
Albumin excretion by the kidney: the effects of volume expansion. J Lab Clin Med (1977) 0.77
Ultrastructure of the kidney in a patient with multiple myeloma. J Pathol Bacteriol (1966) 0.77
Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer use. Am J Nephrol (1986) 0.77
Renal effects of intraperitoneal kappa chain injection. Induction of crystals in renal tubular cells. Lab Invest (1974) 0.77
Defibrination with ancrod: effect on reticuloendothelial clearance of circulating immune complexes. Nephron (1982) 0.77
Renal clearance of human and rat albumins in the rat. Proc Soc Exp Biol Med (1975) 0.77
Effect of aminonucleoside on transport maximum of para-aminohippurate and intrarenal blood flow distribution in rats. J Lab Clin Med (1977) 0.77
The effect of small amounts of antidiuretic hormone on sodium and urate excretion in pregnancy. Am J Obstet Gynecol (1966) 0.77
Maternal renal disease: effect on the fetus. Clin Perinatol (1981) 0.76
The influence of n-6 and n-3 fatty acids on kidney phospholipid composition and on eicosanoid production in aging rats. Lipids (1988) 0.76
Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects. Arch Intern Med (1984) 0.76
The effects of antithymocyte globulin in NZB-NZW F1 mice. Proc Soc Exp Biol Med (1968) 0.76
Antibody to Tamm-Horsfall protein after acute tubular necrosis. Am J Nephrol (1981) 0.75
Antibody production and antigenic specific suppression to bovine serum albumin in uremic rats. Clin Exp Immunol (1982) 0.75
Lymphocytotoxins in epileptic patients receiving phenytoin. Clin Exp Immunol (1977) 0.75
Treatment of membranous glomerulonephropathy. Am J Kidney Dis (1992) 0.75
A preliminary immunologic study of urinary proteins: the questionable value of protein clearances in kidney disease. Can Med Assoc J (1966) 0.75
Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod. Clin Nephrol (1990) 0.75
Acute deterioration in renal function in patients with preexisting renal insufficiency. Arch Intern Med (1984) 0.75
Computerization of the medical record: use in care of patients with endstage renal disease. Kidney Int (1983) 0.75
Treatment of lupus nephritis. Nihon Jinzo Gakkai Shi (1983) 0.75
Treatment of lupus nephritis. Nephron (1977) 0.75
Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia. Nephron (1984) 0.75